Brad Vale - 25 May 2021 Form 4 Insider Report for NEVRO CORP

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 25 May 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 May 2021, 21:02:36 UTC
Source filing: View source filing
Reporting owner signature: /s/ Kashif Rashid, as Attorney-in-Fact for Brad Vale

Key filing fact

Brad Vale filed Form 4 for NEVRO CORP on 26 May 2021.

Key facts

This page summarizes Brad Vale's Form 4 filing for NEVRO CORP.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 May 2021, 21:02.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NVRO transaction

Common Stock

Award

Transaction value: $0
Shares: +1,167
Change %: +17%
Price: $0.000000
Shares after: 8,198
Date: 25 May 2021
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2021 or (ii) the next Annual Meeting following May 25, 2021, subject to the Reporting Person's continued service to the issuer.

Footnote F2

Includes 1,167 RSUs.